Front Page / Home Page - Teaser for Twitter feed

Jan 24, 2012

United receives CE Mark for new CT systems

September 4, 2026

Epione With Touchpanel Ge Health Care

Precision IO to debut new capabilities for Epione system

September 3, 2026

Philips Tvus Transducer

Philips launches eV14-2v transvaginal transducer for OB/GYN imaging

September 3, 2026

Vara nets CE certification for autonomous breast screening AI triage

September 3, 2026

United receives CE Mark for new CT systems

By AuntMinnieEurope.com staff writers

The scanners are built on a twin-ring gantry architecture with dual 16-cm wide coverage Ultrix detectors and two liquid-metal-bearing x-ray tubes.

September 4, 2026

Precision IO to debut new capabilities for Epione system

By AuntMinnieEurope.com staff writers

These include Smart Seg AI for liver tumor segmentation, and compatibility with GE HealthCare's Allia Moveo Interact Touch panel.

September 3, 2026

Epione With Touchpanel Ge Health Care

Philips launches eV14-2v transvaginal transducer for OB/GYN imaging

By AuntMinnie.com staff writers

The transducer supports imaging across routine and complex gynecology exams and early obstetrics.

September 3, 2026

Philips Tvus Transducer

Vara nets CE certification for autonomous breast screening AI triage

By AuntMinnieEurope.com staff writers

Under the certification, exams the system classifies as clearly normal can be reported by AI without a radiologist reading them.

September 3, 2026

MRI shows how hormones affect mood

By Amerigo Allegretto

MRI scans show how higher progesterone levels indicate lower mood.

September 2, 2026

Woman Mother Stressed 400

What to watch for at CIRSE 2026

By Claudia Tschabuschnig

The program spans new treatments, clinical practice, training, and access to IR across Europe.

September 2, 2026

Q&A with Ken Herrmann: Theranostics must move earlier and beyond established targets

By Claudia Tschabuschnig

Prof. Ken Herrmann discusses the expansion of radioligand therapy into earlier treatment lines, the need for new cancer targets, long-term safety, and the challenge of translating innovation into robust clinical evidence.

September 1, 2026

Prof. Ken Herrmann, director of the Department of Nuclear Medicine at University Hospital Essen, pictured fourth from the left, at the opening opening of a new nuclear medicine center in Essen, Germany, focused on theranostics and personalized cancer care.

AI cuts chest CT reporting time

Exploratory modeling suggested an approximate reduction of 0.5 full-time equivalent radiologist workload.

September 1, 2026

Example of AI-assisted pulmonary nodule detection and longitudinal volumetric assessment in a 65-year-old woman with peripheral arterial disease, a 24-pack-year smoking history, emphysema, and a family history of lung cancer. An incidental 8.5-mm right lower lobe pulmonary nodule is identified at CT angiography of the abdomen in July 2022 but does not receive follow-up. Subsequent imaging demonstrates interval growth, and CT-guided biopsy confirms stage IA lung adenocarcinoma. Contrast-enhanced axial chest CT images obtained on February 2, 2024, before robotic-assisted thoracoscopic segmentectomy, show a 12.1-mm spiculated right lower lobe pulmonary nodule. (A) Conventional contrast-enhanced axial chest CT image without AI assistance shows a 12.1-mm spiculated right lower lobe pulmonary nodule. (B) Corresponding CT image with AI-assisted pulmonary nodule detection, automated segmentation, and quantitative nodule assessment identifies a solid pulmonary nodule (nodule #1) measuring 13 × 8 (11) mm, with a volume of 739 mm3, a 45% volumetric increase compared with the previous contrast-enhanced chest CT performed on October 9, 2023 (510 mm3), and an estimated volume doubling time (VDT) of 216 days. (C) AI-generated longitudinal nodule analysis displays automated segmentation of the current (February 2, 2024) and previous (October 9, 2023) CT examinations, 3D nodule reconstruction, and quantitative volumetric assessment for longitudinal follow-up. The AI interface is displayed in the original software language (Dutch).

BIR signs three-year collaboration agreement with IAEA

By AuntMinnieEurope.com staff writers

The agreement aims to boost cooperation in radiology, nuclear medicine, medical physics, and radiation oncology.

September 1, 2026

Bir Full Colour

Bayer's PET agent meets endpoints in phase III cardiac amyloidosis study

Overall sensitivity was 94% (95% CI, 85% to 98%) and specificity was 86% (95% CI, 77% to 92%).

August 31, 2026

This figure shows fused I-124 evuzamitide positron emission tomography (PET)/computed tomography (CT) images from patients without amyloidosis and from patients with ATTR cardiac amyloidosis, early ATTR cardiac amyloidosis, light chain cardiac amyloidosis, gelsolin-mediated amyloidosis, and systemic organ amyloid. The columns represent radiological transaxial, sagittal, and coronal views except for the last row middle and far right columns, which are coronal projections. The blue asterisks represent physiological activity (tracer activity in the stomach and esophagus). The arrowheads represent pathological uptake. Note the small amount of cardiac uptake in the basal septum and the basal lateral walls (likely early ATTR cardiac amyloidosis), splenic uptake and pleural uptake in light chain amyloidosis, and cardiac and kidney uptake in gelsolin-mediated amyloidosis. The bright yellow color represents more tracer uptake.

Video: Ken Herrmann maps nuclear medicine’s next frontiers

By Claudia Tschabuschnig

From earlier PSMA-targeted therapy and new cancer targets to total-body PET and low-dose screening, Prof. Ken Herrmann outlines where nuclear medicine could go next.

August 31, 2026

GEHC's Photonova Spectra photon-counting CT receives CE Mark

By AuntMinnie.com staff writers

The regulatory milestone follows U.S. Food and Drug Administration (FDA) 510(k) clearance in March.

August 31, 2026

GE HealthCare's Photonova Spectra photon-counting CT system.

Page 1 of 1331